Skip to main content
logo
Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
14.89
-0.81 (-5.16%)
At close: Mar 3, 2026, 4:00 PM EST
14.82
-0.07 (-0.47%)
Pre-market: Mar 4, 2026, 4:43 AM EST

Viatris Revenue

In the year 2025, Viatris had annual revenue of $14.30B, down -2.98%. Viatris had revenue of $3.70B in the quarter ending December 31, 2025, with 4.97% growth.

Revenue (ttm)
$14.30B
Revenue Growth
-2.98%
P/S Ratio
1.20
Revenue / Employee
$476,663
Employees
30,000
Market Cap
17.14B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202514.30B-439.40M-2.98%
Dec 31, 202414.74B439.40M3.07%
Dec 31, 202314.30B-439.40M-2.98%
Dec 31, 202214.74B-687.60M-4.46%
Dec 31, 202115.43B3.48B29.14%
Dec 31, 202011.95B445.50M3.87%
Dec 31, 201911.50B66.60M0.58%
Dec 31, 201811.43B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Takeda Pharmaceutical Company28.48B
Teva Pharmaceutical Industries17.26B
Haleon14.85B
Zoetis9.47B
Elanco Animal Health4.72B
Dr. Reddy's Laboratories3.85B
United Therapeutics3.18B
Neurocrine Biosciences2.86B
Revenue Rankings

VTRS News

More News